Eterna Therapeutics Inc
NASDAQ:ERNA
Eterna Therapeutics Inc
NASDAQ:ERNA
Price:
6.34
USD
-6.76%
Market Closed
Market Cap:
$7.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Eterna Therapeutics Inc
NASDAQ:ERNA
|
US |
|
C
|
Carnarvon Energy Ltd
ASX:CVN
|
AU |
|
I
|
Income Opportunity Realty Investors Inc
AMEX:IOR
|
US |
|
H
|
Haldex AB
LSE:0O93
|
SE |
|
E
|
Edgewell Personal Care Co
F:EGZ
|
US |
|
SK Innovation Co Ltd
KRX:096770
|
KR |
|
Skyworth Group Ltd
HKEX:751
|
HK |
|
K
|
Kerry Express (Thailand) PCL
SET:KEX
|
TH |
|
Asia Vital Components Co Ltd
OTC:AVMPF
|
TW |
|
L
|
Link Administration Holdings Ltd
ASX:LNK
|
AU |
|
Celltrion Inc
KRX:068270
|
KR |
|
Alexander & Baldwin Inc (Hawaii)
NYSE:ALEX
|
US |
|
Usinas Siderurgicas de Minas Gerais SA USIMINAS
BOVESPA:USIM5
|
BR |
|
H
|
Hyungji Innovation and Creative Co Ltd
KOSDAQ:011080
|
KR |
|
Reliance Global Group Inc
NASDAQ:RELI
|
US |
|
Profound Medical Corp
TSX:PRN
|
CA |
|
M
|
MapLight Therapeutics Inc
NASDAQ:MPLT
|
US |
Multiples-Based Value
The Multiples-Based Value for Eterna Therapeutics Inc (ERNA) under the Base Case is hidden
USD.
Compared with the current market price of 6.34 USD, the stock appears hidden
.
Multiples-Based Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
ERNA Multiples-Based Value
LOCKED
